Frank DAmelio - Pfizer CFO VP

PFE Stock   12.01  0.16  1.31%   

Insider

Frank DAmelio is CFO VP of Pfizer Inc CDR
Age 66
Address 66 Hudson Boulevard East, New York, NY, United States, 10001-2192
Phone212 733 2323
Webhttps://www.pfizer.com

Pfizer Management Efficiency

The company has return on total asset (ROA) of 0.0331 % which means that it generated a profit of $0.0331 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0454 %, meaning that it generated $0.0454 on every $100 dollars invested by stockholders. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Pfizer's Net Tangible Assets are very stable compared to the past year. As of the 3rd of December 2024, Total Current Assets is likely to grow to about 49.9 B, while Total Assets are likely to drop about 199.2 B.

Similar Executives

Showing other executives

INSIDER Age

Phil FiuzaAtrium Mortgage Investment
N/A
Richard MunroeAtrium Mortgage Investment
N/A
Marianne DobslawAtrium Mortgage Investment
N/A
Dianne WattsWestshore Terminals Investment
N/A
Jennie MoushosWestern Investment
N/A
Glenn DudarWestshore Terminals Investment
N/A
Robert MBAAtrium Mortgage Investment
66
Shelly AnwyllData Communications Management
N/A
FCIS FGIAPerseus Mining
N/A
Darren HoldenLion One Metals
N/A
Bram MBAAtrium Mortgage Investment
N/A
Barbara FranovicWilkinsData Communications Management
N/A
H HollandsWestshore Terminals Investment
66
Steve AkazawaWestshore Terminals Investment
N/A
Jeffrey EdelenLion One Metals
N/A
Sergio MScLion One Metals
N/A
PE MBALion One Metals
65
Jessica VolichPerseus Mining
N/A
Christopher WoodallPerseus Mining
N/A
Tony CALion One Metals
N/A
BSc FAusIMMPerseus Mining
N/A
Pfizer Inc CDR (PFE) is traded on NEO Exchange in Canada and employs 88,000 people. Pfizer is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Pfizer Inc CDR Leadership Team

Elected by the shareholders, the Pfizer's board of directors comprises two types of representatives: Pfizer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pfizer. The board's role is to monitor Pfizer's management team and ensure that shareholders' interests are well served. Pfizer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pfizer's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Young, Advisor
Jennifer Damico, Controller VP
Aamir Malik, Executive Officer
DVM DVM, Chairman CEO
Frank DAmelio, CFO VP
Sally Susman, Executive Officer
Douglas Lankler, Executive Counsel
Rady Johnson, Quality Compliance
Mikael MD, Chief Development
Albert DVM, Chairman CEO
Payal Becher, Chief VP
Christopher CFA, VP Officer
Andreas Panayiotou, Global Officer
Francesca DeMartino, Chief Officer
Lidia Fonseca, Executive Officer
Angela Hwang, Chief Bus
David Denton, Chief VP
Annette Doherty, Head Sciences

Pfizer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pfizer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Pfizer

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pfizer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will appreciate offsetting losses from the drop in the long position's value.

Moving together with Pfizer Stock

  0.62AEMC Alaska Energy MetalsPairCorr
  0.78CMC Cielo Waste SolutionsPairCorr

Moving against Pfizer Stock

  0.82LQWD LQwD FinTech CorpPairCorr
  0.45ERC Eros Resources CorpPairCorr
The ability to find closely correlated positions to Pfizer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pfizer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pfizer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pfizer Inc CDR to buy it.
The correlation of Pfizer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pfizer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pfizer Inc CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pfizer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Pfizer Stock

Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.